Print

Print


Commission highlights initiatives to fight Parkinson's disease

[Date: 2003-04-11] Marking world Parkinson's disease day on 11 April, the
European Commission is highlighting the results of two EU funded projects
aimed at improving research into the disease and the rehabilitation of
sufferers.

The PARREHA (Parkinsonians rehabilitation) project is designed to help
patients overcome their symptoms through visual and audio stimuli, while
the EuroPa (European cooperative network for research, diagnosis and
therapy of Parkinson's disease) aims to improve understanding and treatment
of Parkinson's through the networking of clinical centres in various
European countries.

EU Commissioner for Research, Philippe Busquin, highlighted the potential
contribution of the two projects: 'EU research can help to improve the
quality of life of people affected by this debilitating disorder. The
creation of research networks allows the pooling of Europe's best
scientists to reach real breakthroughs in finding solutions for this disease.'

Parkinson's disease currently affects over 500,000 Europeans, and the
proportion of sufferers is continually growing due to the aging of the
population as a whole. As well as the obvious medical problems associated
with the condition, it is also one of the most costly brain disorders
known, with a German study suggesting that annual therapy costs total
around 6,000 euro per patient.

Parkinson's disease is a movement dysfunction. The PARREHA project,
supported by 1.7 million euro under the IST section of the Fifth Framework
Programme (FP5) and co funded by the Commission's Joint Research Centre
(JRC), has developed a set of information technology tools to assist the
rehabilitation of Parkinson's patients suffering mobility problems.

Audio and visual stimulation has been known to suddenly relieve sufferers
of all their symptoms, a phenomenon known as 'Kinesia Paradoxa' and still
not completely understood. Through the use of personalised virtual reality
glasses, virtual exercise and training systems, and personalised remote
consultation, the PARREHA project has developed tools that can
significantly improve on the results of traditional rehabilitation methods.

Prototypes of the PARREHA system have shown impressive results in helping
lethargic patients become significantly more active, and the project
consortium are now aiming to market the results on a commercial basis.

The EuroPa network is an association of clinical centres from 11 countries
(Austria, the Czech Republic, France, Germany, Israel, Italy, Portugal,
Spain, Sweden, the Netherlands and the UK) and was set up with 1.7 million
euro in funding under the Life Quality section of FP5.

The main aim of the network is the creation of a clinical trials network
using Internet technology, which will establish a central patient registry
to help find patients who fit the necessary clinical profile for a
particular trial. Medical information will be stored under pseudonyms to
protect patient privacy, and by combining the knowledge and resources of
all project partners in a database of precise medical information will
speed up and improve research into Parkinson's.

After the end of the initial EU funding period, which is due to end in
September 2004, the network will be transformed into a self sufficient and
independent organisation. Specialists from other clinics and European
countries will then be able to join the network and increase its scope and
collaboration.

The Commission intends to fund more projects focussing on brain research
under the Sixth Framework Programme, with conditions such as Parkinson's
and Alzheimer's a high priority. Mr Busquin also announced the Commission's
intention, along with the European Parliament, to organise a conference to
discuss how to build a 'true European Brain Research Area'.

For further information, please consult the following web addresses:

http://www.parreha.com/

http://www.europarkinson.net/

http://www.cordis.lu/lifescihealth/

CORDIS RTD-NEWS
European Communities.
http://dbs.cordis.lu/

janet paterson: an akinetic rigid subtype, albeit primarily perky, parky
pd: 56-41-37 cd: 56-44-43 tel: 613-256-8340 email: [log in to unmask]
my newsletter: http://groups.yahoo.com/group/newvoicenews/
my website: http://www.geocities.com/janet313/

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn